Xiao J - Search Results

1

[Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].

Xiao J, Wang SS, Huang Y, Chen LK, Guan ZZ, Huang HQ, Xia ZJ, Xu RH, Lin TY. Xiao J, et al. Ai Zheng. 2006 Sep;25(9):1173-7. Ai Zheng. 2006. PMID: 16965665 Chinese.

2

[FOLFOX versus PLF regimen in treatment of advanced gastric adenocarcinoma].

Ye S, Rong J, Lin TY, Xiao J, Huang Y, Zhai LZ. Ye S, et al. Among authors: xiao j. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(9):1599-602. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18819876 Chinese.

3

[Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].

Fu XH, Wang SS, Huang Y, Xiao J, Zhai LZ, Xia ZJ, Huang HQ, Sun XF, Lin TY. Fu XH, et al. Among authors: xiao j. Ai Zheng. 2008 Nov;27(11):1197-203. Ai Zheng. 2008. PMID: 19000453 Free article. Chinese.

4

[Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma: a report of 90 cases].

Zhai LZ, Xiao J, Fu XH, Ye S, Guo CC, Huang JJ, Tian Y, Lin HL, Lin TY. Zhai LZ, et al. Among authors: xiao j. Ai Zheng. 2009 Jul;28(7):734-9. doi: 10.5732/cjc.008.10818. Ai Zheng. 2009. PMID: 19624901 Free article. Chinese.

5

[Effect of KRAS mutation on efficacy of Cetuximab combined with chemotherapy in advanced colorectal cancer patients].

Pu XX, Deng YH, Xu F, Xiao J, Guo HQ, Huang H, Tian Y, He YJ, Lin TY. Pu XX, et al. Among authors: xiao j. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Nov;12(6):594-7. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19921572 Chinese.

6

Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience.

Zhai L, Guo C, Cao Y, Xiao J, Fu X, Huang J, Huang H, Guan Z, Lin T. Zhai L, et al. Among authors: xiao j. Int J Hematol. 2010 Jan;91(1):78-86. doi: 10.1007/s12185-009-0461-8. Epub 2009 Dec 23. Int J Hematol. 2010. PMID: 20033628

7

5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells.

Deng YH, Pu XX, Huang MJ, Xiao J, Zhou JM, Lin TY, Lin EH. Deng YH, et al. Among authors: xiao j. Chin J Cancer. 2010 Sep;29(9):810-5. doi: 10.5732/cjc.010.10134. Chin J Cancer. 2010. PMID: 20800023 Free article.

8

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.

Huang JJ, Li ZM, Huang Y, Huang Y, Tian Y, He XX, Xiao J, Lin TY. Huang JJ, et al. Among authors: xiao j. Invest New Drugs. 2012 Feb;30(1):223-35. doi: 10.1007/s10637-010-9558-4. Epub 2010 Oct 20. Invest New Drugs. 2012. PMID: 20960030

9

Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial.

Xiao J, Chen Z, Li W, Yang Z, Huang Y, Zheng J, Deng Y, Wang L, Ren D, Peng J, Lan P, Wang J. Xiao J, et al. Cancer Chemother Pharmacol. 2015 Jul;76(1):21-7. doi: 10.1007/s00280-015-2763-2. Epub 2015 May 8. Cancer Chemother Pharmacol. 2015. PMID: 25952796 Clinical Trial.

10

Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective Trial.

Xiao J, Cai Z, Li W, Yang Z, Gong J, Huang Y, Deng Y, Wu X, Wang L, Peng J, Ren D, Lan P, Wang J. Xiao J, et al. J Cancer. 2015 May 26;6(7):636-42. doi: 10.7150/jca.11738. eCollection 2015. J Cancer. 2015. PMID: 26078794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,360 results

Search Page

Filters